ETFsMSCI Europe Health Care 35/20 Capped Index
State Street / SPDR
State Street® SPDR® MSCI Europe Health Care UCITS ETF
HLTH LSEAccumulatingPhysical, full replicationIrelandNot PEA-eligible
Last close · EUR
256.43EUR
+0.21% · +€0.55
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
HLTHBase
- Fund charges
- 0.18%PRIIPs ongoing costs
- Fund size
- €663.1Mall share classes
- Return 1Y
- +22.2%
- Sharpe 3Y
- 0.43
- Volatility 1Y
- 18.9%annualised
- Holdings
- 38Fund holdings
Performance
Compare
- HLTH+22.2%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| HLTH | +17.7% | +11.9% | +17.9% | +14.4% | +22.2% | +32.7% | +34.2% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.3% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +20.5% | +12.5% | +10.0% | +0.1% | +8.1% | -32.9% | -30.6% |
Risk and return
Sharpe ratio · 3Y
0.43
Below MSCI World · 1.24- Return p.a.
- +9.3%
- Volatility
- 17.7%
- Max loss
- -26.6%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
HLTH
0.43
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 75.7%
- Holdings
- 38
- As of
- 1Roche Holding LtdCH149905998317.10%
- 2Novartis AGCH001200526715.12%
- 3AstraZeneca PLCGB000989529214.35%
- 4Novo Nordisk A/S Class BDK00624983336.94%
- 5Sanofi SAFR00001205785.19%
- 6GSK plcGB00BN7SWP635.18%
- 7EssilorLuxottica SAFR00001216673.10%
- 8Bayer AGDE000BAY00173.01%
- 9argenx SENL00108321762.88%
- 10Lonza Group AGCH00138410172.85%
Countries
Classified 100.0%
Switzerland43.6%
GB
FR
DK
DE
BE
NL
- Largest
- 43.6%Switzerland
- Top 3
- 75.8%
- Effective number
- 3.81 / HHI
Market cap
Weight vs holdings
75.7%of the fund sits in the top 10 holdings
75.7%24.3%
WeightHoldings
1028
- Holdings 1-10
- Holdings 11-38
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.